JP2008501795A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501795A5
JP2008501795A5 JP2007527196A JP2007527196A JP2008501795A5 JP 2008501795 A5 JP2008501795 A5 JP 2008501795A5 JP 2007527196 A JP2007527196 A JP 2007527196A JP 2007527196 A JP2007527196 A JP 2007527196A JP 2008501795 A5 JP2008501795 A5 JP 2008501795A5
Authority
JP
Japan
Prior art keywords
cells
stem cell
isolated
extract
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007527196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501795A (ja
Filing date
Publication date
Priority claimed from US10/864,788 external-priority patent/US20050090004A1/en
Application filed filed Critical
Priority claimed from PCT/US2005/005052 external-priority patent/WO2005123123A2/en
Publication of JP2008501795A publication Critical patent/JP2008501795A/ja
Publication of JP2008501795A5 publication Critical patent/JP2008501795A5/ja
Withdrawn legal-status Critical Current

Links

JP2007527196A 2004-06-08 2005-02-16 ハイブリッド幹細胞の治療的再プログラミングおよび成熟 Withdrawn JP2008501795A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/864,788 US20050090004A1 (en) 2003-01-16 2004-06-08 Stem cell maturation for all tissue lines
US58814604P 2004-07-15 2004-07-15
PCT/US2005/005052 WO2005123123A2 (en) 2004-06-08 2005-02-16 Therapeutic reprogramming, hybrid stem cells and maturation

Publications (2)

Publication Number Publication Date
JP2008501795A JP2008501795A (ja) 2008-01-24
JP2008501795A5 true JP2008501795A5 (enExample) 2008-04-03

Family

ID=35355246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527196A Withdrawn JP2008501795A (ja) 2004-06-08 2005-02-16 ハイブリッド幹細胞の治療的再プログラミングおよび成熟

Country Status (7)

Country Link
EP (1) EP1758989A2 (enExample)
JP (1) JP2008501795A (enExample)
AU (1) AU2005253923A1 (enExample)
BR (1) BRPI0511889A (enExample)
CA (1) CA2567692A1 (enExample)
RU (1) RU2006147263A (enExample)
WO (1) WO2005123123A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090252711A1 (en) * 2006-05-11 2009-10-08 Andrew Craig Boquest Stem Cells And Methods Of Making And Using Stem Cells
WO2008104994A2 (en) 2007-02-28 2008-09-04 Advinus Therapeutics Private Limited 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
CN101679365A (zh) 2007-06-08 2010-03-24 艾德维纳斯医疗私人有限公司 作为葡萄糖激酶激活剂的新型吡咯-2-甲酰胺衍生物、它们的制造方法和药学应用
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
EP2402327B1 (en) 2010-06-29 2018-03-07 Impetis Biosciences Ltd. Acetamide compounds as glucokinase activators, their process and medicinal applications
EP2796873A1 (en) * 2013-04-25 2014-10-29 QGel SA Method for a cell-based drug screening assay and the use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9912662A (pt) * 1998-07-31 2001-06-05 Genzyme Corp Melhoria de função cardìaca por transplante de célula de ramo mesenquimal
US20020136709A1 (en) * 2000-12-12 2002-09-26 Nucleus Remodeling, Inc. In vitro-derived adult pluripotent stem cells and uses therefor
JP2004248505A (ja) * 2001-09-21 2004-09-09 Norio Nakatsuji 移植抗原の一部または全てを欠除したes細胞由来の未分化な体細胞融合細胞およびその製造
CA2474766A1 (en) * 2002-01-16 2003-07-31 Chauncey Sayre Stem cell maturation for all tissue types
AU2003229388A1 (en) * 2002-05-31 2003-12-19 Apollo Life Sciences Limited Cell recovery
AU2003295444A1 (en) * 2002-11-15 2004-06-15 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells

Similar Documents

Publication Publication Date Title
Melton ‘Stemness’: definitions, criteria, and standards
Bongso et al. Taking stem cells to the clinic: major challenges
Cameron et al. Improved development of human embryonic stem cell‐derived embryoid bodies by stirred vessel cultivation
JP2012139246A5 (enExample)
EA201000858A1 (ru) Ядерный фактор перепрограммирования
JP2008212150A5 (enExample)
JP2019004912A5 (enExample)
JP2007516728A5 (enExample)
McGuckin et al. Potential for access to embryonic‐like cells from human umbilical cord blood
RU2011124900A (ru) Культура плюрипотентных стволовых клеток на микроносителях
JP2018526992A5 (enExample)
WO2015054526A3 (en) Methods of mammalian retinal stem cell production and applications
JP2020517283A5 (enExample)
RU2016121409A (ru) Суспендирование и кластеризация плюрипотентных стволовых клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
MX2013006958A (es) Medio del cultivo celular.
WO2010108005A3 (en) Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells
WO2007115337A8 (en) Chondrocyte differentiation from human embryonic stem cells and their use in tissue engineering
CN104560870A (zh) 一种制备蜕膜间充质干细胞的方法
McGuckin et al. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling
Carvalho et al. Characterization of decellularized heart matrices as biomaterials for regular and whole organ tissue engineering and initial in-vitro recellularization with ips cells
JP2012143229A5 (enExample)
NZ591812A (en) Cell culture method to form aggregates
WO2011084747A3 (en) Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
Deng et al. Isolation and characterization of buffalo (bubalus bubalis) amniotic mesenchymal stem cells derived from amnion from the first trimester pregnancy
CN104178456B (zh) 一种人诱导多能干细胞的传代方法及应用